Statement of Ownership (sc 13g)
February 08 2019 - 4:48PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
|
|
SCHEDULE 13G
|
|
Under the Securities Exchange Act of 1934
|
(Amendment No. )*
|
|
BioLineRx
Ltd.
|
(Name of Issuer)
|
|
Ordinary
Shares, par value NIS 0.10 per share
|
(Title of Class of Securities)
|
|
09071M106
|
(CUSIP Number)
|
|
February
5, 2019
|
(Date of Event Which Requires Filing of this Statement)
|
|
|
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
|
¨
|
Rule 13d-1(b)
|
x
|
Rule 13d-1(c)
|
¨
|
Rule 13d-1(d)
|
|
(Page 1 of 7 Pages)
|
______________________________
*The remainder of
this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required
in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("
Act
") or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).
CUSIP No. 09071M106
|
13G
|
Page
2
of 7 Pages
|
1
|
NAME OF REPORTING PERSON
Senvest Management, LLC
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
¨
(b)
¨
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
7,538,845 (represented by 4,813,845 ADSs and
including 2,725,000 Ordinary Shares (represented by 2,725,000 ADSs) issuable upon exercise of warrants)
|
7
|
SOLE DISPOSITIVE POWER
0
|
8
|
SHARED DISPOSITIVE POWER
7,538,845 (represented by 4,813,845 ADSs and
including 2,725,000 Ordinary Shares (represented by 2,725,000 ADSs) issuable upon exercise of warrants)
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,538,845 (represented by 4,813,845 ADSs and
including 2,725,000 Ordinary Shares (represented by 2,725,000 ADSs) issuable upon exercise of warrants)
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
¨
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.18%
|
12
|
TYPE OF REPORTING PERSON
OO, IA
|
|
|
|
|
|
CUSIP No. 09071M106
|
13G
|
Page
3
of 7 Pages
|
1
|
NAME OF REPORTING PERSON
Richard Mashaal
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
¨
(b)
¨
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
7,538,845 (represented by 4,813,845 ADSs and
including 2,725,000 Ordinary Shares (represented by 2,725,000 ADSs) issuable upon exercise of warrants)
|
7
|
SOLE DISPOSITIVE POWER
0
|
8
|
SHARED DISPOSITIVE POWER
7,538,845 (represented by 4,813,845 ADSs and
including 2,725,000 Ordinary Shares (represented by 2,725,000 ADSs) issuable upon exercise of warrants)
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,538,845 (represented by 4,813,845 ADSs and
including 2,725,000 Ordinary Shares (represented by 2,725,000 ADSs) issuable upon exercise of warrants)
|
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
¨
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.18%
|
12
|
TYPE OF REPORTING PERSON
IN, HC
|
|
|
|
|
|
CUSIP No. 09071M106
|
13G
|
Page
4
of 7 Pages
|
Item 1(a).
|
Name of Issuer.
|
|
|
|
BioLineRx Ltd. (the "
Issuer
")
|
Item 1(b).
|
Address of Issuer's Principal Executive Offices.
|
|
|
|
2 HaMa'ayan Street
Modi'in 7177871
Israel
|
Item 2(a).
|
Name of Person Filing.
|
|
|
|
This statement is filed by Senvest Management, LLC and Richard Mashaal.
The reported securities are held in the accounts of Senvest Master
Fund, LP, Senvest Technology Partners Master Fund, LP and Senvest Global (KY), LP (collectively, the "
Investment Vehicles
").
Senvest Management, LLC may be deemed to beneficially
own the securities held by the Investment Vehicles by virtue of Senvest Management, LLC's position as investment manager of the
Investment Vehicles. Mr. Mashaal may be deemed to beneficially own the securities held by the Investment Vehicles by virtue of
Mr. Mashaal's status as the managing member of Senvest Management, LLC. None of the foregoing should be construed in and of itself
as an admission by any Reporting Person as to beneficial ownership of the securities reported herein.
|
|
|
Item 2(b).
|
Address of Principal Business Office.
|
|
|
|
Senvest Management, LLC
540 Madison Avenue, 32
nd
Floor
New York, New York 10022
Richard Mashaal
c/o Senvest Management, LLC
540 Madison Avenue, 32
nd
Floor
New York, New York 10022
|
|
|
Item 2(c).
|
Place of Organization.
|
|
|
|
Senvest Management, LLC – Delaware
Richard Mashaal – Canada
|
Item 2(d).
|
Title of Class of Securities.
|
|
|
|
Ordinary Shares, par value NIS 0.10 per share
|
Item 2(e).
|
CUSIP Number.
|
|
|
|
09071M106
|
CUSIP No. 09071M106
|
13G
|
Page
5
of 7 Pages
|
Item 3.
|
If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a:
|
|
(a)
|
¨
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
|
(b)
|
¨
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
|
(c)
|
¨
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
|
(d)
|
¨
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
|
(e)
|
¨
|
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
¨
|
An employee benefit plan or endowment fund in
accordance with § 240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
¨
|
A parent holding company or control person in
accordance with §240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
¨
|
A savings association as defined in Section 3(b)
of the Federal Deposit Insurance Act (12 U.S.C.1813);
|
|
(i)
|
¨
|
A church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
(j)
|
¨
|
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
|
|
(k)
|
¨
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution.
|
Item 4.
|
Ownership.
|
|
|
|
The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentages set forth in this Schedule 13G are calculated based upon an aggregate of 142,930,636 Ordinary Shares, which is the sum of (i) 114,930,636 Ordinary Shares outstanding as of December 26, 2018 as reported in the Issuer's Registration Statement on Form F-3 filed with the Securities and Exchange Commission on December 26, 2018 and (ii) 28,000,000 Ordinary Shares underlying the American Depositary Receipts offered pursuant to the Prospectus Supplement filed pursuant to Rule 424(b)(5) with the Securities and Exchange Commission on February 5, 2019, and assumes the exercise of the reported warrants.
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
|
|
|
Not applicable.
|
CUSIP No. 09071M106
|
13G
|
Page
6
of 7 Pages
|
Item 6.
|
Ownership of More Than Five Percent on Behalf of Another Person.
|
|
|
|
The Investment Vehicles have the right to receive and the power to direct the receipt of dividends from, and the proceeds from the sale of, the securities reported herein.
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
|
|
|
Not applicable.
|
Item 8.
|
Identification and Classification of Members of the Group.
|
|
|
|
Not applicable.
|
Item 9.
|
Notice of Dissolution of Group.
|
|
|
|
Not applicable.
|
Item 10.
|
Certification.
|
|
|
|
By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
|
CUSIP No. 09071M106
|
13G
|
Page
7
of 7 Pages
|
SIGNATURE
After reasonable inquiry and to the best of
my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and
correct.
Date: February 8, 2019
|
|
|
SENVEST MANAGEMENT, LLC
|
|
|
|
By:
/s/ Bobby Trahanas
|
|
Name: Bobby Trahanas
|
|
Title: Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
/s/ Richard Mashaal
|
|
RICHARD MASHAAL
|
BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From Apr 2023 to Apr 2024